Journal Article > ResearchFull Text
Popul Health Metr. 2018 July 3; Volume 16 (Issue 1); DOI:10.1186/s12963-018-0167-3
Isanaka S, Hedt-Gauthier BL, Grais RF, Allen BGS
Popul Health Metr. 2018 July 3; Volume 16 (Issue 1); DOI:10.1186/s12963-018-0167-3
Many health programs can assess coverage using standardized cluster survey methods, but estimating the coverage of nutrition programs presents a special challenge due to low disease prevalence. Used since 2012, the Semi-Quantitative Evaluation of Access and Coverage (SQUEAC) employs both qualitative and quantitative methods to identify key barriers to access and estimate coverage of therapeutic feeding programs. While the tool has been increasingly used in programs, the validity of certain methodological elements has been the subject of debate.
Journal Article > ResearchFull Text
Popul Health Metr. 2012 September 4 (Issue 1); DOI:10.1186/1478-7954-10-18.
Caleo GNC, Sy AP, Balandine S, Polonsky JA, Palma PP, et al.
Popul Health Metr. 2012 September 4 (Issue 1); DOI:10.1186/1478-7954-10-18.
During 2010, a community-based, sentinel site prospective surveillance system measured mortality, acute malnutrition prevalence, and the coverage of a Médecins Sans Frontières (MSF) intervention in four sous-préfectures of Lobaye prefecture in southwestern Central African Republic. We describe this surveillance system and its evaluation.
Journal Article > ReviewFull Text
Popul Health Metr. 2013 September 10; Volume 11 (Issue 1); DOI:10.1186/1478-7954-11-17
Jafri RZ, Ali A, Messonnier NE, Tevi-Benissan C, Durrheim DN, et al.
Popul Health Metr. 2013 September 10; Volume 11 (Issue 1); DOI:10.1186/1478-7954-11-17
Neisseria meningitidis is one of the leading causes of bacterial meningitis globally and can also cause sepsis, pneumonia, and other manifestations. In countries with high endemic rates, the disease burden places an immense strain on the public health system. The worldwide epidemiology of invasive meningococcal disease (IMD) varies markedly by region and over time. This review summarizes the burden of IMD in different countries and identifies the highest-incidence countries where routine preventive programs against Neisseria meningitidis would be most beneficial in providing protection. Available epidemiological data from the past 20 years in World Health Organization and European Centre for Disease Prevention and Control collections and published articles are included in this review, as well as direct communications with leading experts in the field. Countries were grouped into high-, moderate-, and low-incidence countries. The majority of countries in the high-incidence group are found in the African meningitis belt; many moderate-incidence countries are found in the European and African regions, and Australia, while low-incidence countries include many from Europe and the Americas. Priority countries for vaccine intervention are high- and moderate-incidence countries where vaccine-preventable serogroups predominate. Epidemiological data on burden of IMD are needed in countries where this is not known, particularly in South- East Asia and Eastern Mediterranean regions, so evidence-based decisions about the use of meningococcal vaccines can be made.